113OEntrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001 L Paz-Ares,R C Doebele, A F Farago,S V Liu,S P Chawla,D Tosi, C M Blakely,J C Krauss,D Sigal,L Bazhenova,T John,B Besse,J Wolf,T Seto, E Chow-Maneval,C Ye,B Simmons, G D DemetriANNALS OF ONCOLOGY（2019）引用 25|浏览54暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
